01875

3.3751.50%
UG

Ulf Grawunder

Independent Non-executive Director

Dr. Ulf Grawunder, Ph.D., is Independent Non-executive Director of BioDlink International Company Limited from April 29, 2026. Dr. Grawunder is Independent Director of Adagene Inc. from March 2024. Dr. Grawunder is Independent Non-Executive Director of WuXi XDC Cayman Inc. from November 17, 2023. Dr. Grawunder joined the WuXi XDC Cayman Inc. in November 2023. Dr. Grawunder is Entrepreneur-in-Residence of BiomedVC AG from April 2026. Dr. Grawunder joined the BiomedVC AG in April 2026. Dr. Grawunder was Founder and Chief Executive Officer of NBE-Therapeutics GmbH. Dr. Grawunder joined the NBE-Therapeutics GmbH in June 2012. Dr. Grawunder was Co-Founder and Chief Scientific Officer of Agenus Switzerland Inc. Dr. Grawunder joined the Agenus Switzerland Inc. in 2002. Dr. Grawunder was Member of Scientific Advisory Board of Araris Biotech AG from June 2024 to June 2025. Dr. Grawunder was employed at Araris Biotech AG until June 2025. Dr. Grawunder was Venture Partner of Pureos Partners AG from January 17, 2023. Dr. Grawunder joined the Pureos Partners AG on January 17, 2023. Dr. Grawunder has Doctorate in Cellular Biology from Universität Basel in 1994, NULL from Washington University School of Medicine, NULL from Keck School of Medicine of USC, Bachelor's in Biochemistry from Universitat Bayreuth in 1988, Master's in Biochemistry from Universitat Bayreuth in 1991.

Positions